Pazopanib Completed Phase 4 Trials for Metastatic Renal Cell Carcinoma ( mRCC) Other

IndicationsStatusPurposePhase
CompletedOther4
clinicaltrials.gov IdentifierTitleDrugs
NCT02555748Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma